[Prostatic carcinoma screening: sense ur nonsense?]
- PMID: 19657603
- DOI: 10.1007/s00508-009-1199-2
[Prostatic carcinoma screening: sense ur nonsense?]
Similar articles
-
Perspective: Enforce the clinical guidelines.Nature. 2015 Dec 17;528(7582):S123. doi: 10.1038/528S123a. Nature. 2015. PMID: 26672782 No abstract available.
-
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581. BMJ. 2018. PMID: 30185545 Free PMC article. No abstract available.
-
Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.Int J Urol. 2009 Sep;16(9):711-12. Int J Urol. 2009. PMID: 19777638 No abstract available.
-
Prostate cancer screening--the evidence, the recommendations, and the clinical implications.JAMA. 2011 Dec 28;306(24):2721-2. doi: 10.1001/jama.2011.1891. JAMA. 2011. PMID: 22203543 No abstract available.
-
PSA Screening for Prostate Cancer.Am Fam Physician. 2015 May 1;91(9):Online. Am Fam Physician. 2015. PMID: 25955746 Review. No abstract available.
Cited by
-
[Austrian patient information materials on PSA-screening do not meet international evidence-based standards].Wien Med Wochenschr. 2011 Feb;161(3-4):89-98. doi: 10.1007/s10354-010-0855-5. Epub 2011 Jan 25. Wien Med Wochenschr. 2011. PMID: 21253813 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical